- Home
- PCRX vs CRMD Comparison
PCRX vs CRMD Comparison
Compare PCRX & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- CRMD
- Stock Information
- Founded
- PCRX 2006
- CRMD 2006
- Country
- PCRX United States
- CRMD United States
- Employees
- PCRX N/A
- CRMD N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- PCRX Health Care
- CRMD Health Care
- Exchange
- PCRX Nasdaq
- CRMD Nasdaq
- Market Cap
- PCRX 604.7M
- CRMD 738.4M
- IPO Year
- PCRX 2011
- CRMD 2010
- Fundamental
- Price
- PCRX $22.38
- CRMD $12.35
- Analyst Decision
- PCRX Buy
- CRMD Strong Buy
- Analyst Count
- PCRX 10
- CRMD 6
- Target Price
- PCRX $27.60
- CRMD $15.67
- AVG Volume (30 Days)
- PCRX 787.3K
- CRMD 1.3M
- Earning Date
- PCRX 02-27-2025
- CRMD 03-11-2025
- Dividend Yield
- PCRX N/A
- CRMD N/A
- EPS Growth
- PCRX N/A
- CRMD N/A
- EPS
- PCRX N/A
- CRMD N/A
- Revenue
- PCRX $694,957,000.00
- CRMD $12,262,234.00
- Revenue This Year
- PCRX $4.83
- CRMD N/A
- Revenue Next Year
- PCRX $2.16
- CRMD $246.41
- P/E Ratio
- PCRX N/A
- CRMD N/A
- Revenue Growth
- PCRX 4.40
- CRMD 41184.20
- 52 Week Low
- PCRX $11.16
- CRMD $2.89
- 52 Week High
- PCRX $34.01
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- PCRX 71.48
- CRMD 69.85
- Support Level
- PCRX $18.18
- CRMD $11.74
- Resistance Level
- PCRX $22.88
- CRMD $13.09
- Average True Range (ATR)
- PCRX 1.14
- CRMD 0.70
- MACD
- PCRX 0.32
- CRMD 0.38
- Stochastic Oscillator
- PCRX 96.36
- CRMD 87.17
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.